Clinical Trial Update: Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (CL-010) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating early bactericidal activity in pulmonary tuberculosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Snippet

Sponsor: Global Alliance for TB Drug Development | Conditions: Pulmonary Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2016-03-09